Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
11
HEPA Quote, Financials, Valuation and Earnings
Last price:
$0.79
Seasonality move
:
-25.16%
Day range:
$0.02 - $0.02
52-week range:
$0.02 - $2.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.60x
Volume:
84.3M
Avg. volume:
23.7M
1-year change:
-99.08%
Market cap:
$4.4K
Revenue:
--
EPS (TTM):
-$4.38
Hepion Pharmaceuticals Number of Institutional Trades
Hepion Pharmaceuticals Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$722K
(Last 6 Months)
Current Institutional Ownership Percentage
1.78%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$2.1M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Hepion Pharmaceuticals Institutional Ownership
-
What Percentage Of HEPA Is Owned by Institutions?
1.78% of HEPA is owned by institutions.
-
How Many Institutions Own HEPA Shares?
Hepion Pharmaceuticals stock is owned by 41 institutional shareholders at this time.
-
Have Institutions Been Buying HEPA Stock?
Yes, institutions have bought 365.8K shares of HEPA in the last quarter.
-
Have Institutions Been Selling HEPA Stock?
Yes, institutions have sold 2.5M shares of HEPA over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
